Showing 2,413 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV

Editor's pick
Gilead press release
20 November 2020
Treatment outcomes & life expectancy

H.I.V. Death Rates Fell by Half 2010-2018, C.D.C. Says

Editor's pick
New York Times
20 November 2020
Treatment outcomes & life expectancy

Millions of people are on treatment for HIV: why are so many still dying?

Editor's pick
The Conversation
18 November 2020
HIV treatment for children & young people

New neonatal liquid formulations of dolutegravir have comparable bioavailability to dispersible paediatric tablet

Editor's pick
i-Base
16 November 2020
Improving HIV care

Escalate HIV Adherence Strategies Amid COVID-19

Editor's pick
Medscape (requires free registration)
16 November 2020
Weight gain & lipodystrophy

Women Show Higher INSTI-Associated Weight Gain and Incident Diabetes Mellitus Than Men

Editor's pick
Infectious Disease Advisor
12 November 2020
Weight gain & lipodystrophy

More Research Points to Weight Increases on TAF-Containing HIV Treatment

Editor's pick
TheBodyPro
27 October 2020
Changing treatment

Switching HIV Regimen to Biktarvy Is Safe and Effective for the Long Term

Editor's pick
POZ
19 October 2020
Treatment guidelines

Perinatal Exposure to HIV Requires Specialized, Coordinated Care

Editor's pick
American Journal of Managed Care
19 October 2020
Injectable & long-acting HIV treatment

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

Editor's pick
ViiV Healthcare press release
16 October 2020
Resistance

Multidrug Resistance Still Boosts Death Risk in 31,000-Person Italian Study

Editor's pick
NATAP
13 October 2020
People with limited treatment options

Patients with HIV and four-class drug resistance have high disease burden

Editor's pick
Healio
11 October 2020
New & experimental HIV treatments

Capsid inhibitor lenacapavir, dosed six-monthly, has high barrier to drug resistance and no cross-resistance to other classes

Editor's pick
i-Base
9 October 2020
Coronavirus

BHIVA ‘2nd COVID peak’ guidance for HIV clinics - plain English version

Editor's pick
BHIVA
8 October 2020
Treatment simplification strategies

GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen

Editor's pick
FiercePharma
7 October 2020
Clinical trials

No more excuses: Making HIV research work for women

Editor's pick
Sophia Forum
29 September 2020
Diabetes

HIV drugs could prevent diabetes, study suggests

Editor's pick
EurekAlert
24 September 2020
Adherence

Tanzania: Financial incentives improve HIV viral suppression, retention in care

Editor's pick
Healio
18 September 2020
PrEP science

Q&A: What clinicians should know about starting, stopping and restarting PrEP

Editor's pick
Healio
14 September 2020
Health problems & ageing

Among Women, HIV Is Tied to High Rates of Chronic Health Conditions

Editor's pick
POZ
11 September 2020
Weight gain & lipodystrophy

Switch From Efavirenz to Integrase Strand Transfer Inhibitors Related to Weight Gain

Editor's pick
Infectious Disease Advisor
11 September 2020
Resistance

Antiretroviral therapy fails to treat one-third of HIV patients in Malawi hospital

Editor's pick
EurekAlert
3 September 2020
New & experimental HIV treatments

New Long-Acting Injectable HIV Drug Shows Promise in Monkey Study

Editor's pick
POZ
2 September 2020
Starting treatment

Dovato Shows Promise as a Rapid Test-and-Treat HIV Regimen

Editor's pick
POZ
1 September 2020